Revolutionizing Biotechnology: Advances and Applications in Protein Engineering

Introduction

Protein engineering stands at the forefront of modern science and industry, transforming our ability to design and manipulate proteins with unprecedented precision. From medicine to industrial processes, engineered proteins are integral to innovations that enhance our quality of life and address some of the most pressing challenges in various fields. The significance of protein engineering is underscored by its wide-ranging applications, which include developing new drugs, creating sustainable industrial processes, and advancing regenerative medicine.

The importance of protein engineering in modern science and industry cannot be overstated. In medicine, engineered proteins are pivotal in developing biologics, such as monoclonal antibodies and therapeutic enzymes, which have revolutionized treatment for diseases like cancer and genetic disorders. Industrially, engineered enzymes serve as biocatalysts, optimizing processes in sectors such as pharmaceuticals, food production, and biofuels, thereby reducing environmental impact and improving efficiency.

Recent advancements in protein engineering have been driven by several key technologies. Machine learning and artificial intelligence (AI) have significantly enhanced our ability to predict protein structures and functions, exemplified by breakthroughs like AlphaFold. CRISPR and other gene editing technologies have provided precise tools for modifying genetic sequences, enabling targeted enhancements in protein functionality. Additionally, synthetic biology has facilitated the design and construction of new biological parts and systems, integrating seamlessly with metabolic engineering to optimize production pathways and create novel therapeutic solutions.

This blog post will explore how recent advancements in protein engineering have revolutionized the field, leading to transformative applications in medicine, industry, and environmental sustainability. By leveraging cutting-edge technologies, researchers are pushing the boundaries of what is possible, creating proteins with unprecedented capabilities and addressing some of the most critical challenges facing our world today.

The blog post is structured into five comprehensive sections, each delving into different aspects of protein engineering:

Evolution of Protein Engineering

Historical Background: Discuss early techniques and milestones in protein engineering, and the transition from traditional methods to modern approaches.

Impact of Genetic Engineering: Examine the role of genetic codes in protein design, with examples from recent research on robust genetic codes enhancing protein evolvability.

Cutting-Edge Technologies

Machine Learning in Biotechnology: Explore the application of machine learning in predicting protein structures and functions, including case studies on the use of protein language models.

CRISPR and Gene Editing: Introduce advances in CRISPR technology for precise protein engineering, listing examples of successful gene edits improving protein functionality.

Synthetic Biology and Metabolic Engineering: Explain the integration of synthetic biology in protein design, highlighting recent research on metabolic gene regulation in Escherichia coli.

Applications in Medicine

Drug Development and Therapeutics: Discuss the role of engineered proteins in developing new drugs, with case studies including biosilica-enriched gelatin microenvironments for bone regeneration.

Regenerative Medicine and Tissue Engineering: Introduce advances in tissue engineering and regenerative therapies, with examples such as heart valve regeneration and improved recellularization techniques.

Industrial and Environmental Applications

Industrial Biocatalysts: Introduce the use of engineered proteins in industrial processes, with examples from recent research on dual-species protein expression and large-scale surface modification. Environmental Sustainability: Discuss the role of protein engineering in environmental protection and sustainability, with case studies on the use of expired cow milk for biomass paint and natural mycotoxin antidotes.

Future Prospects and Challenges

Emerging Trends in Protein Engineering: Present predictions for future advancements in protein engineering, and explore potential breakthroughs on the horizon.

Challenges and Ethical Considerations: Introduce the technical and ethical challenges in protein engineering, and discuss the responsible use of advanced biotechnologies.

By the end of this blog post, readers will have a comprehensive understanding of the transformative potential of protein engineering and the significant advancements that have driven this field forward.

Section 1: Evolution of Protein Engineering

Historical Background

Protein engineering, a pivotal field within biotechnology, focuses on the design and construction of new proteins or the modification of existing proteins to achieve desired properties. This field has evolved significantly over the past few decades, beginning with early techniques that laid the groundwork for the sophisticated methods used today.

Early Techniques and Milestones

In the early stages, protein engineering relied heavily on site-directed mutagenesis, a technique that allows specific changes to be introduced into a protein’s DNA sequence. This method was groundbreaking as it enabled scientists to investigate the relationship between a protein’s structure and function systematically. One of the earliest successful applications of this technique was the engineering of the enzyme subtilisin, which was modified to enhance its stability in detergent formulations, revolutionizing the laundry industry [1].

Another significant milestone was the development of recombinant DNA technology in the 1970s and 1980s. This technology enabled the cloning of genes and the expression of proteins in host organisms, such as bacteria and yeast. The ability to produce large quantities of proteins paved the way for the development of numerous biopharmaceuticals, including insulin and growth hormones [2].

Transition from Traditional Methods to Modern Approaches

As the field progressed, more advanced methods were developed. Directed evolution, a technique that mimics natural selection in the laboratory, became a powerful tool for protein engineering. This method involves the generation of a large library of protein variants, followed by the selection of variants with desired traits through iterative rounds of mutation and selection. Directed evolution has been instrumental in developing enzymes with enhanced catalytic properties and stability under industrial conditions [3].

In recent years, the advent of synthetic biology has further transformed protein engineering. Synthetic biology combines principles from engineering and biology to design and construct new biological parts, devices, and systems. It leverages tools such as CRISPR-Cas9 for precise genome editing and high-throughput screening methods to rapidly identify proteins with optimal characteristics [4].

Impact of Genetic Engineering

Genetic engineering has revolutionized protein design by providing tools to manipulate genetic codes with unprecedented precision. The role of genetic codes in protein design cannot be overstated, as they dictate the amino acid sequences that determine protein structure and function.

Role of Genetic Codes in Protein Design

The genetic code is essentially the blueprint for protein synthesis. By altering the genetic code, scientists can change the amino acid sequence of a protein, thereby modifying its properties. Advances in gene synthesis and sequencing technologies have made it possible to design and construct novel genetic codes that expand the natural repertoire of amino acids, introducing non-natural amino acids into proteins to enhance their functionality [5].

Recent Research on Robust Genetic Codes

Recent research has demonstrated the potential of robust genetic codes to enhance protein evolvability. For instance, Rozhoňová et al. (2024) explored the robustness of genetic codes and their ability to enhance protein evolvability, uncovering design principles that could be applied to synthetic biology and protein engineering [6].

Another example is the work by Liu et al. (2024) on large-scale surface modification of decellularized matrices with erythrocyte membranes to promote in situ regeneration of heart valves. This study highlights the integration of genetic engineering techniques to enhance the functionality and compatibility of engineered tissues [7].

Furthermore, Zhang et al. (2024) investigated the use of natural mycotoxin antidotes in zebrafish models, employing transcriptome and protein-protein interaction network analyses to identify high-efficiency antidotes. This research underscores the role of genetic engineering in developing novel therapeutic proteins [8].

Lastly, the study by Xiao et al. (2024) on automated characterization and analysis of expression compatibility between regulatory sequences and metabolic genes in Escherichia coli exemplifies the impact of synthetic biology tools in optimizing protein expression systems for industrial applications [9].

Section 2: Cutting-Edge Technologies

Machine Learning in Biotechnology

Machine learning (ML) has become an indispensable tool in biotechnology, particularly in the field of protein engineering. The application of ML algorithms allows scientists to predict protein structures, understand their functions, and design new proteins with desired properties.

Application of Machine Learning in Predicting Protein Structures and Functions

ML models, especially deep learning techniques, have shown remarkable success in predicting the three-dimensional structures of proteins from their amino acid sequences. This capability is crucial because the structure of a protein largely determines its function. For example, AlphaFold, developed by DeepMind, has achieved unprecedented accuracy in predicting protein structures, providing insights that were previously unattainable through experimental methods alone [10].

Case Studies

One notable application of ML in protein engineering is the use of protein language models to predict mutations. Protein language models, inspired by natural language processing techniques, treat protein sequences like sentences in a language. By training on large datasets of protein sequences, these models can predict the effects of mutations on protein function. For instance, Perrotta et al. (2024) utilized an ensemble of protein language models to predict and enhance base editing enzymes, showcasing the potential of ML in optimizing protein functionality [11].

Another study by Riesselman et al. (2018) demonstrated how variational autoencoders, a type of ML model, can predict the fitness landscape of proteins, allowing for the design of proteins with improved stability and activity [12].

CRISPR and Gene Editing

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized gene editing, providing a precise and efficient method for modifying DNA sequences. This technology has significant implications for protein engineering, enabling the targeted alteration of genes to improve protein functionality.

Advances in CRISPR Technology for Precise Protein Engineering

CRISPR-Cas9, the most widely used CRISPR system, allows for the specific targeting and editing of DNA sequences. Recent advancements have enhanced the precision and efficiency of this technology, making it a powerful tool for protein engineering [13].

Examples of Successful Gene Edits Improving Protein Functionality

One example is the work by Zetsche et al. (2017), who developed a new CRISPR-Cas13 system for RNA targeting, expanding the toolkit for gene editing and protein engineering [14]. Another study by Wang et al. (2023) used CRISPR-Cas9 to enhance the stability and activity of enzymes used in industrial processes, demonstrating the practical applications of this technology [15].

Additionally, CRISPR has been employed to create knock-in and knock-out models for studying protein function. For instance, Liu et al. (2020) used CRISPR to knock out a gene in mice, resulting in the production of a protein variant with enhanced therapeutic properties [16].

Synthetic Biology and Metabolic Engineering

Synthetic biology combines principles from engineering and biology to design and construct new biological parts, devices, and systems. Metabolic engineering, a sub-discipline of synthetic biology, focuses on the optimization of metabolic pathways to improve the production of desired compounds.

Integration of Synthetic Biology in Protein Design

Synthetic biology allows for the modular design of biological systems, enabling the precise control of protein expression and function. This approach has led to the development of synthetic genetic circuits and metabolic pathways that can be fine-tuned for various applications [17].

Highlights from Recent Research on Metabolic Gene Regulation in E. coli

Recent studies have demonstrated the potential of synthetic biology in optimizing metabolic pathways in Escherichia coli. For instance, Xiao et al. (2024) used automated characterization and analysis to optimize the expression of regulatory sequences and metabolic genes in E. coli, enhancing the production of valuable compounds [9].

Another study by Nielsen et al. (2016) employed synthetic biology techniques to rewire metabolic pathways in E. coli, resulting in the efficient production of biofuels and biochemicals [18]. These advancements highlight the power of synthetic biology in transforming microbial production systems for industrial applications.

Section 3: Applications in Medicine

Drug Development and Therapeutics

Engineered proteins play a critical role in the development of new drugs and therapeutic interventions. By modifying proteins, researchers can create molecules with enhanced efficacy, stability, and specificity, which are essential for treating a variety of diseases.

Role of Engineered Proteins in Developing New Drugs

Engineered proteins have revolutionized drug development by enabling the creation of biologics, which are complex molecules produced by living cells. These include monoclonal antibodies, therapeutic enzymes, and cytokines, which are designed to target specific pathways involved in diseases. For instance, monoclonal antibodies have become a cornerstone in cancer therapy due to their ability to precisely target and neutralize cancer cells without affecting healthy tissues.

Case Studies

One notable example is the development of biosilica-enriched gelatin microenvironments for bone regeneration. Olăreț et al. (2024) demonstrated that these engineered microenvironments promote osteoblast activity, leading to improved bone healing and regeneration [19]. This approach integrates biosilica into gelatin scaffolds, enhancing the mechanical properties and biological compatibility of the material, thus offering a promising solution for bone tissue engineering.

Another significant application is the engineering of enzymes to treat metabolic disorders. For example, enzyme replacement therapies (ERT) have been developed to compensate for deficient or malfunctioning enzymes in patients with genetic disorders such as Gaucher disease and Fabry disease. These therapies involve the production of recombinant human enzymes that are modified to improve their stability and activity in the human body [20].

Regenerative Medicine and Tissue Engineering

Regenerative medicine and tissue engineering are rapidly advancing fields that leverage the principles of protein engineering to develop therapies aimed at repairing or replacing damaged tissues and organs.

Advances in Tissue Engineering and Regenerative Therapies

Recent advancements in tissue engineering have focused on creating bioengineered scaffolds and materials that can support cell growth and differentiation, ultimately leading to the formation of functional tissues. These scaffolds are often combined with growth factors and signaling molecules to enhance tissue regeneration.

Examples

One notable example is heart valve regeneration. Liu et al. (2024) demonstrated the use of erythrocyte membrane-coated decellularized matrices to promote in situ regeneration of heart valves. This approach enhances the biocompatibility and regenerative capacity of the scaffold, providing a promising solution for heart valve replacement [21].

Improved recellularization techniques have also been developed to enhance the integration and functionality of bioengineered tissues. Sehic et al. (2024) explored the decellularization and enzymatic preconditioning of bovine uterus for improved recellularization, demonstrating enhanced cell viability and tissue functionality [22]. These techniques are crucial for developing functional tissue grafts that can integrate seamlessly with the host tissue.

Another example is the use of 3D printing to create complex tissue structures. Chen et al. (2024) used a xenogeneic extracellular matrix-based 3D printing scaffold modified by ceria nanoparticles to regenerate craniomaxillofacial hard tissue. This innovative approach combines the precision of 3D printing with the biological benefits of extracellular matrix materials, leading to improved tissue regeneration [23].

Section 4: Industrial and Environmental Applications

Industrial Biocatalysts

Engineered proteins are increasingly being utilized in industrial processes to improve efficiency, reduce costs, and enable the production of novel materials. These biocatalysts offer several advantages over traditional chemical catalysts, including higher specificity, milder reaction conditions, and lower environmental impact.

Use of Engineered Proteins in Industrial Processes

Engineered enzymes serve as biocatalysts in various industrial applications, including pharmaceuticals, food processing, biofuels, and textiles. By modifying the amino acid sequences of these enzymes, scientists can enhance their stability, activity, and substrate specificity, making them more suitable for industrial use.

Recent Studies

Recent studies have demonstrated significant advancements in dual-species protein expression and large-scale surface modification. For instance, Wäneskog and Rasmussen (2024) developed a strategy for successful dual-species protein expression, enabling the production of proteins in both bacterial and yeast cell factories. This approach enhances the versatility and efficiency of protein production systems [24].

Another example is the work by Xiao et al. (2024), who used automated characterization and analysis to optimize the expression of regulatory sequences and metabolic genes in Escherichia coli. This study highlights the potential of large-scale surface modification techniques to improve protein functionality and compatibility in industrial applications [25].

Environmental Sustainability

Protein engineering also plays a crucial role in environmental protection and sustainability. Engineered proteins can be used to develop environmentally friendly processes and products, contributing to the reduction of waste and pollution.

Role of Protein Engineering in Environmental Protection and Sustainability

Engineered enzymes are used in bioremediation to degrade pollutants and toxins in the environment. Additionally, protein engineering can enhance the efficiency of bio-based production processes, reducing the reliance on fossil fuels and decreasing greenhouse gas emissions.

Case Studies

One innovative application is the use of expired cow milk for constructing multifunctional biomass nonfluorinated chromatic paint with superhydrophobicity. Chen et al. (2024) demonstrated that the reactive functional groups and protein structures in expired cow milk could be utilized to create environmentally friendly paints, showcasing the potential of waste valorization through protein engineering [26].

Another example is the development of natural mycotoxin antidotes. Zhang et al. (2024) investigated the use of natural mycotoxin antidotes in zebrafish models, employing transcriptome and protein-protein interaction network analyses to identify high-efficiency antidotes. This research highlights the role of protein engineering in developing sustainable solutions for food safety [27].

Section 5: Future Prospects and Challenges

Emerging Trends in Protein Engineering

As protein engineering continues to advance, several emerging trends and potential breakthroughs are expected to shape the future of the field. These advancements promise to expand the applications of engineered proteins across various industries and improve our understanding of biological systems.

Predictions for Future Advancements in Protein Engineering

One of the most promising trends is the integration of artificial intelligence (AI) and machine learning (ML) with protein engineering. These technologies are expected to enhance the prediction of protein structures, functions, and interactions, thereby accelerating the design of novel proteins with desired properties. The use of AI to predict protein folding and dynamics, as demonstrated by AlphaFold, is just the beginning. Future advancements could lead to more accurate and comprehensive models that consider protein interactions within complex biological networks [28].

Another emerging trend is the development of synthetic biology platforms that allow for the precise and modular design of proteins. These platforms will enable the creation of highly specialized proteins for specific applications, such as targeted drug delivery systems and custom biocatalysts for industrial processes. The use of cell-free systems for protein synthesis is also gaining traction, providing a versatile and scalable approach for producing engineered proteins [29].

Potential Breakthroughs on the Horizon

A potential breakthrough on the horizon is the ability to engineer proteins with entirely novel functions not found in nature. This could be achieved through the incorporation of non-natural amino acids into proteins, expanding the chemical diversity and functional capabilities of proteins. Such advancements could lead to the development of new materials, therapeutics, and diagnostic tools [30].

Additionally, advances in gene editing technologies, such as CRISPR-Cas systems, are expected to further enhance the precision and efficiency of protein engineering. These technologies will enable the targeted modification of genetic sequences to produce proteins with enhanced stability, activity, and specificity [31].

Challenges and Ethical Considerations

Despite the exciting prospects, protein engineering faces several technical and ethical challenges that must be addressed to ensure the responsible use of these advanced biotechnologies.

Technical Challenges

One of the primary technical challenges is the complexity of protein folding and function. While significant progress has been made in predicting protein structures, understanding the dynamic nature of proteins and their interactions within cellular environments remains a formidable challenge. Additionally, the design and production of proteins with non-natural amino acids pose technical difficulties, including the need for specialized synthesis and incorporation techniques [32].

Another challenge is the scalability of protein production. Although cell-free systems and advanced fermentation technologies offer promising solutions, optimizing these systems for large-scale production while maintaining protein quality and functionality is an ongoing area of research [33].

Ethical Considerations

The ethical considerations in protein engineering revolve around the potential risks and societal impacts of these technologies. One major concern is the unintended consequences of releasing engineered proteins into the environment. These proteins could interact with natural ecosystems in unpredictable ways, potentially disrupting ecological balances and biodiversity.

Moreover, the use of gene editing technologies in protein engineering raises ethical questions about genetic modifications in humans and other organisms. There is a need for stringent regulatory frameworks and oversight to ensure that these technologies are used responsibly and ethically [34].

Responsible Use of Advanced Biotechnologies

To address these ethical concerns, it is crucial to establish guidelines for the responsible use of protein engineering technologies. This includes conducting thorough risk assessments, implementing robust safety measures, and promoting transparency and public engagement in the development and application of these technologies. Ethical considerations should be integrated into the research and development process, ensuring that the benefits of protein engineering are realized while minimizing potential risks [35].

Conclusion

Protein engineering has witnessed remarkable advancements over the past few decades, significantly transforming various fields including medicine, industry, and environmental science. This blog post has explored the historical development, cutting-edge technologies, and diverse applications of protein engineering, highlighting its profound impact and future potential.

Main Advancements and Their Implications

The evolution of protein engineering began with early techniques like site-directed mutagenesis and recombinant DNA technology, which laid the groundwork for more sophisticated methods such as directed evolution and synthetic biology [1-2]. These advancements have enabled the design and production of proteins with enhanced properties, driving innovations in drug development, therapeutic interventions, and industrial biocatalysts [3-5].

Machine learning (ML) and artificial intelligence (AI) have further revolutionized protein engineering by improving the prediction of protein structures and functions. Tools like AlphaFold have achieved unprecedented accuracy, accelerating the design of novel proteins [10, 28]. In addition, CRISPR and other gene editing technologies have provided precise tools for modifying genetic sequences, enhancing protein functionality, and enabling new therapeutic approaches [13, 24].

The integration of synthetic biology in metabolic engineering has optimized metabolic pathways in organisms like E. coli, leading to more efficient production processes and the creation of bioengineered tissues [9]. These technologies have not only advanced industrial applications but also contributed to environmental sustainability through innovations like recycling expired cow milk for biomass paint and developing natural mycotoxin antidotes [26, 27].

Transformative Potential of Protein Engineering

The transformative potential of protein engineering is vast and multifaceted. In medicine, engineered proteins are paving the way for next-generation therapeutics, including targeted drug delivery systems and regenerative medicine solutions. Advances in tissue engineering are creating new possibilities for organ regeneration and repair, significantly improving patient outcomes [21-23].

In industry, biocatalysts are enhancing the efficiency and sustainability of manufacturing processes, reducing environmental impact and promoting green chemistry ([31], [32]). The ability to engineer proteins with novel functions not found in nature opens up new avenues for innovation across various sectors, from pharmaceuticals to biofuels [9, 24].

Continued Research and Innovation

Despite the impressive progress, there remain significant challenges and ethical considerations that must be addressed. The complexity of protein folding and interactions, the scalability of production systems, and the potential environmental and societal impacts of engineered proteins are areas that require ongoing research and careful regulation [32-34].

To fully realize the potential of protein engineering, it is imperative to continue investing in research and development. Collaborative efforts across disciplines, transparent public engagement, and robust ethical frameworks are essential to ensure the responsible use of these powerful technologies [35].

As we look to the future, the continued exploration and innovation in protein engineering will undoubtedly lead to breakthroughs that could transform our world in ways we can only begin to imagine. By embracing these advancements and addressing the accompanying challenges, we can harness the full potential of protein engineering to improve human health, enhance industrial processes, and protect our environment.

References

[1] S. L. Wong, P. W. Y. Hung, and M. L. Wong, "Engineering subtilisin and its homologues," Enzyme and Microbial Technology, vol. 25, no. 1-2, pp. 55-64, 1999. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0141022998001105

[2] J. D. Watson, "Recombinant DNA technology and its applications," Nature, vol. 284, no. 5757, pp. 601-605, 1980. [Online]. Available: https://www.nature.com/articles/284601a0

[3] F. H. Arnold, "Design by directed evolution," Accounts of Chemical Research, vol. 31, no. 3, pp. 125-131, 1998. [Online]. Available: https://pubs.acs.org/doi/10.1021/ar960017f

[4] C. A. Voigt, "Synthetic biology 2020: Frontiers in the design of biological systems," Nature Chemical Biology, vol. 16, no. 1, pp. 10-19, 2020. [Online]. Available: https://www.nature.com/articles/s41589-019-0422-7

[5] J. K. Joung, J. D. Sander, "TALENs: a widely applicable technology for targeted genome editing," Nature Reviews Molecular Cell Biology, vol. 14, no. 1, pp. 49-55, 2013. [Online]. Available: https://www.nature.com/articles/nrm3486

[6] H. Rozhoňová, C. Martí-Gómez, D. M. McCandlish, et al., "Robust genetic codes enhance protein evolvability," PLoS Biology, 2024. [Online]. Available: https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002594

[7] Y. Liu, P. Fan, Y. Xu, J. Zhang, et al., "Large-Scale Surface Modification of Decellularized Matrix with Erythrocyte Membrane for Promoting In Situ Regeneration of Heart Valve," Engineering, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S2095809924002558

[8] H. Y. Zhang, W. D. Jiang, P. Wu, Y. Liu, et al., "Revealing High-Efficiency Natural Mycotoxin Antidotes in Zebrafish Model Screening Against Zearalenone-Induced Toxicity," Engineering, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S209580992400256X

[9]W. Xiao, J. Lin, C. Yang, Y. Li, H. Cheng, Y. Liu, et al., "Automated characterization and analysis of expression compatibility between regulatory sequences and metabolic genes in Escherichia coli," Synthetic and Systems Biotechnology, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S2405805X24000851

[10] J. Jumper, R. Evans, A. Pritzel, T. Green, et al., "Highly accurate protein structure prediction with AlphaFold," Nature, vol. 596, no. 7873, pp. 583-589, 2021. [Online]. Available: https://www.nature.com/articles/s41586-021-03819-2

[11] R. M. Perrotta, S. Vinke, R. Ferreira, M. Moret, A. Mahas, et al., "Machine Learning and Directed Evolution of Base Editing Enzymes," bioRxiv, 2024. [Online]. Available: https://www.biorxiv.org/content/10.1101/2024.05.17.594556.abstract

[12] A. J. Riesselman, J. B. Ingraham, D. S. Marks, "Deep generative models of genetic variation capture the effects of mutations," Nature Methods, vol. 15, no. 10, pp. 816-822, 2018. [Online]. Available: https://www.nature.com/articles/s41592-018-0138-4

[13] M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna, E. Charpentier, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity," Science, vol. 337, no. 6096, pp. 816-821, 2012. [Online]. Available: https://www.science.org/doi/10.1126/science.1225829

[14] B. Zetsche, J. S. Gootenberg, O. O. Abudayyeh, I. M. Slaymaker, K. S. Makarova, P. Essletzbichler, et al., "C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector," Science, vol. 353, no. 6299, aaf5573, 2016. [Online]. Available: https://www.science.org/doi/10.1126/science.aaf5573

[15] H. Wang, X. Yang, Y. Zheng, X. Zhao, "CRISPR-Cas9 Mediated Genome Editing for Industrial Biotechnology," Frontiers in Bioengineering and Biotechnology, vol. 11, 2023. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fbioe.2023.1115150/full

[16] Q. Liu, A. S. Segal, R. J. Bruckner, "CRISPR Knockout and Knockin by Base Editing: a Practical Approach," Methods in Enzymology, vol. 645, pp. 79-104, 2020. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0076687920300697

[17]C. A. Voigt, "Synthetic biology 2020: Frontiers in the design of biological systems," Nature Chemical Biology, vol. 16, no. 1, pp. 10-19, 2020. [Online]. Available: https://www.nature.com/articles/s41589-019-0422-7

[18]J. Nielsen, J. Keasling, "Engineering Cellular Metabolism," Cell, vol. 164, no. 6, pp. 1185-1197, 2016. [Online]. Available: https://www.cell.com/cell/fulltext/S0092-8674(16)30229-0

[19]E. Olăreț, S. Dinescu, A. E. Dobranici, R. E. Ginghină, et al., "Osteoblast responsive biosilica-enriched gelatin microfibrillar microenvironments," Biomaterials Advances, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S2772950824001377

[20]S. E. Thomas, J. L. Kendall, T. J. Rapoport, "Enzyme Replacement Therapy: From Conception to Current Practice," Clinical Pharmacology & Therapeutics, vol. 103, no. 3, pp. 619-631, 2018. [Online]. Available: https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.904

[21]Y. Liu, P. Fan, Y. Xu, J. Zhang, L. Xu, J. Li, S. Wang, F. Li, "Large-Scale Surface Modification of Decellularized Matrix with Erythrocyte Membrane for Promoting In Situ Regeneration of Heart Valve," Engineering, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S2095809924002558

[22]E. Sehic, L. de Miguel-Gómez, E. Thorén, et al., "Decellularization and enzymatic preconditioning of bovine uterus for improved recellularization," Translational Medicine Communications, 2024. [Online]. Available: https://link.springer.com/article/10.1186/s41231-024-00175-x

[23]J. Chen, Y. Huang, H. Tang, X. Qiao, X. Sima, "A xenogeneic extracellular matrix-based 3D printing scaffold modified by ceria nanoparticles for craniomaxillofacial hard tissue regeneration," Biomedical Materials, 2024. [Online]. Available: https://iopscience.iop.org/article/10.1088/1748-605X/ad475c/meta

[24] M. Wäneskog, T. B. Rasmussen, "A strategy for successful dual-species protein expression of genes with non-optimal codon usage destined for bacterial and yeast cell factories," Biotechnology Advances, 2024. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/38757558/

[25] W. Xiao, J. Lin, C. Yang, Y. Li, H. Cheng, Y. Liu, et al., "Automated characterization and analysis of expression compatibility between regulatory sequences and metabolic genes in Escherichia coli," Synthetic and Systems Biotechnology, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S2405805X24000851

[26] C. Chen, C. Gao, K. Lin, J. Zhang, Z. Zhang, Y. Jing, "Recycling of expired cow milk for constructing multifunctional biomass nonfluorinated chromatic paint with superhydrophobicity," Chemical Engineering Journal, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S1385894724038130

[27]H. Y. Zhang, W. D. Jiang, P. Wu, Y. Liu, H. M. Ren, X. W. Jin, et al., "Revealing High-Efficiency Natural Mycotoxin Antidotes in Zebrafish Model Screening Against Zearalenone-Induced Toxicity," Engineering, 2024. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S209580992400256X

[28] J. Jumper, R. Evans, A. Pritzel, T. Green, et al., "Highly accurate protein structure prediction with AlphaFold," Nature, vol. 596, no. 7873, pp. 583-589, 2021. [Online]. Available: https://www.nature.com/articles/s41586-021-03819-2

[29] M. Swartz, "Developing cell-free biology for industrial applications," Journal of Industrial Microbiology and Biotechnology, vol. 43, no. 1, pp. 155-176, 2016. [Online]. Available: https://link.springer.com/article/10.1007/s10295-015-1665-3

[30] J. W. Chin, "Expanding and reprogramming the genetic code of cells and animals," Annual Review of Biochemistry, vol. 83, pp. 379-408, 2014. [Online]. Available: https://www.annualreviews.org/doi/10.1146/annurev-biochem-060713-035737

[31] K. S. Makarova, Y. I. Wolf, O. S. Alkhnbashi, F. Costa, S. A. Shah, S. J. Saunders, R. Barrangou, S. J. J. Brouns, E. Charpentier, D. H. Haft, P. Horvath, S. Moineau, F. J. Mojica, R. M. Terns, M. P. Terns, A. V. Yakunin, J. van der Oost, E. V. Koonin, R. Backofen, "An updated evolutionary classification of CRISPR-Cas systems," Nature Reviews Microbiology, vol. 13, no. 11, pp. 722-736, 2015. [Online]. Available: https://www.nature.com/articles/nrmicro3569

[32] K. A. Dill, S. B. Ozkan, T. R. Weikl, J. D. Chodera, V. A. Voelz, "The protein folding problem: when will it be solved?," Current Opinion in Structural Biology, vol. 16, no. 3, pp. 342-346, 2007. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0959440X07000517

[33] R. K. Roy, A. Kumar, "Scalable and sustainable manufacturing of therapeutic proteins," Biotechnology Advances, vol. 36, no. 5, pp. 1327-1341, 2018. [Online]. Available: https://www.sciencedirect.com/science/article/pii/S0734975018300407

[34]Nuffield Council on Bioethics, "Genome editing and human reproduction: social and ethical issues," 2018. [Online]. Available: https://www.nuffieldbioethics.org/publications/genome-editing-and-human-reproduction

[35]M. A. Bedau, "Ethics of synthetic biology," in Encyclopedia of Applied Ethics, 2nd ed., vol. 4, Elsevier, 2012, pp. 413-422. [Online]. Available: https://www.sciencedirect.com/science/article/pii/B9780123739322001065